NYSE:BAX - Baxter International Stock Price, News, & Analysis

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, November 13th. Stockholders of record on Monday, December 3rd will be given a dividend of $0.19 per share on Wednesday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date is Friday, November 30th. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has initiated a share buyback plan on Tuesday, November 13th 2018, which allows the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 6.1% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 17.67% and a net margin of 10.90%. Baxter International's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the company posted $0.64 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 31st 2019. View Earnings Estimates for Baxter International.

Baxter International updated its fourth quarter earnings guidance on Wednesday, October, 31st. The company provided earnings per share (EPS) guidance of $0.71-0.73 for the period, compared to the Thomson Reuters consensus estimate of $0.77. Baxter International also updated its FY 2018 guidance to $2.98-3.00 EPS.

16 Wall Street analysts have issued 1-year target prices for Baxter International's shares. Their predictions range from $70.00 to $85.00. On average, they expect Baxter International's share price to reach $76.1250 in the next twelve months. This suggests a possible upside of 10.1% from the stock's current price. View Analyst Price Targets for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News headlines about BAX stock have trended negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Baxter International earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the company's share price in the near future.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ResMed (RMD), ABIOMED (ABMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), ICU Medical (ICUI), Penumbra (PEN), Insulet (PODD) and Globus Medical (GMED).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include Gateway Investment Advisers LLC (0.08%), Retirement Systems of Alabama (0.06%), Nisa Investment Advisors LLC (0.04%), Sit Investment Associates Inc. (0.03%), Palisade Asset Management LLC (0.03%) and Gulf International Bank UK Ltd (0.02%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., Boston Advisors LLC, Gulf International Bank UK Ltd, First Citizens Bank & Trust Co., Carroll Financial Associates Inc., Oakbrook Investments LLC, First Midwest Bank Trust Division and DNB Asset Management AS. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau and Third Point Llc. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc., New England Research & Management Inc., Town & Country Bank & Trust CO dba First Bankers Trust CO, Steward Partners Investment Advisory LLC, State of Alaska Department of Revenue, Palisade Asset Management LLC, BKD Wealth Advisors LLC and Retirement Systems of Alabama. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $69.12.

Baxter International has a market capitalization of $35.94 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

The official website for Baxter International is http://www.baxter.com.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]